Yahoo Finance • 5 days ago
WARSAW, Ind., Dec. 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the 44th Annual J.P.... Full story
Yahoo Finance • 8 days ago
This article first appeared on GuruFocus. Product Revenue: Increased 907% to $2.7 million in Q4 FY2025; 163% to $9.1 million for the full fiscal year 2025. License Revenue: $3 million in fiscal 2025 from the expanded exclusive distributio... Full story
Yahoo Finance • 11 days ago
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Morgan Stanley upgraded Roku (ROKU) to... Full story
Yahoo Finance • 11 days ago
Thinkstock Quick Read The rotation trade had another run on Wall Street Monday, as tech stocks led the selling once again. While the move away from the AI/Data center trade has gained some strength, the reality is that with a likely thir... Full story
Yahoo Finance • 13 days ago
Wondering if Zimmer Biomet Holdings is quietly becoming a value opportunity, or if the recent weakness is a warning sign? Let us walk through what the numbers are really saying about the stock. The share price is down about 2.9% over the l... Full story
Yahoo Finance • last month
SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and... Full story
Yahoo Finance • last month
Company Logo The Hip Replacement industry is poised for substantial growth, projected to reach US$ 10.24 billion by 2033, up from US$ 6.92 billion in 2024, at a CAGR of 4.45% between 2025 and 2033. This expansion is driven by increased aw... Full story
Yahoo Finance • last month
Company Logo The viscosupplementation market is projected to grow robustly, reaching US$ 10.16 billion by 2033 from US$ 4.66 billion in 2024, with a CAGR of 9.02% from 2025 to 2033. This minimally invasive treatment involves injecting hya... Full story
Yahoo Finance • last month
Zimmer Biomet Holdings has seen its consensus analyst price target decrease slightly from $104.84 to $102.92, reflecting a cautious reassessment among market watchers. While updated product launches and strategic moves such as the FNA acqu... Full story
Yahoo Finance • last month
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Gauzy Ltd. (NASDAQ:GAUZ) and Zimmer Biomet Holdings, Inc. (NYSE:ZBH).... Full story
Yahoo Finance • last month
LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) on behalf of investors concerning the Company’s possible... Full story
Yahoo Finance • last month
BENSALEM, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible vio... Full story
Yahoo Finance • last month
LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) inv... Full story
Yahoo Finance • 2 months ago
Henkell Freixenet was honored with the Ponce de León Company of the Year Award, while Iván Tornos, Chairman, President & CEO of Zimmer Biomet Holdings, Inc. (S&P 500), received the Ponce de León Corporate Leader of the... Full story
Yahoo Finance • 2 months ago
We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the worst-performing stocks on Wednesday. Zimmer dropped its share prices by 15.15 percent on Wednesday to end at $87.55... Full story
Yahoo Finance • 2 months ago
Reports Q3 revenue $2B, consensus $2.01B. “Our third quarter performance was anchored by 5.6% organic revenue growth in our critical U.S. business, driven by accelerated adoption of our key new products referred to as the ‘Magnificent Seve... Full story
Yahoo Finance • 2 months ago
The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are pointing lower ahead of the open, as investors react to news that US household debt has climbed to a fresh all-time high and the 10-year Treasury yield... Full story
Yahoo Finance • 2 months ago
PAUL FAITH / AFP / Getty Images Seagate Technology was the best-performing stock in the S&P 500 Wednesday afternoon Key Takeaways Tech stocks rebounded from Tuesday's losses to help boost the major U.S. equities indexes Wednesday afterno... Full story
Yahoo Finance • 2 months ago
Zimmer Biomet, the maker of knee and hip replacements, missed on quarterly sales estimates and lowered the top end of its outlook for full-year organic revenue growth. Continue Reading View Comments... Full story
Yahoo Finance • 2 months ago
By Sahil Pandey (Reuters) -Zimmer Biomet Holdings cut its 2025 organic revenue growth forecast following weakness in Latin America and emerging markets in Europe, sending shares 15% lower on Wednesday. The medical device maker kept its o... Full story